Therefore, it is reasonable to expect that increases in endogenous IFNα/β during viral infections or chronic administration of type I IFNs may have long-term impacts on HSC response to subsequent inflammatory stimuli. The gene discussed is IFNA2; the disease is viral infectious disease.